Report overview
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
This report aims to provide a comprehensive presentation of the global market for Anti-Tumor Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Tumor Drugs. This report contains market size and forecasts of Anti-Tumor Drugs in global, including the following market information:
Global Anti-Tumor Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Tumor Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Tumor Drugs companies in 2022 (%)
The global Anti-Tumor Drugs market was valued at US$ 97070 million in 2022 and is projected to reach US$ 127900 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In China, Anti-tumor Drug key players include AstraZeneca, Merck & Co., Roche, Celgene, Johnson & Johnson, etc.
United States is the largest market, followed by Japan, and Europe.
We surveyed the Anti-Tumor Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Tumor Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Tumor Drugs Market Segment Percentages, by Type, 2022 (%)
Surgical
Chemotherapy
Radiation
Targeted
Immunotherapy
Global Anti-Tumor Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Tumor Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Use
Clinic Use
Household
Other
Global Anti-Tumor Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Tumor Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Tumor Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Tumor Drugs revenues share in global market, 2022 (%)
Key companies Anti-Tumor Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Tumor Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Celgene
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Tumor Drugs, market overview.
Chapter 2: Global Anti-Tumor Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Tumor Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Tumor Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Tumor Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
